Praxis Precision Medicines, Inc.
PRAXNASDAQHealthcare● Active
$259.74
+$5.74(+2.26%)
Market Cap$5.5B
P/E Ratio—
52W High$366.52
52W Low$37.19
Praxis Precision Medicines, Inc. (PRAX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRAX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.15B | $0.09B | $0.15B | $0.00B |
| Gross Profit | ($0.00B) | ($0.14B) | ($0.08B) | ($0.15B) | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.27B | $0.15B | $0.09B | $0.16B | $0.12B |
| G&A Expenses | $0.06B | $0.06B | $0.04B | $0.06B | $0.05B |
| Total Operating Expenses | $0.33B | $0.06B | $0.04B | $0.06B | $0.17B |
| Operating Income | ($0.33B) | ($0.20B) | ($0.13B) | ($0.21B) | ($0.17B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.02B | $0.02B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.30B) | ($0.18B) | ($0.12B) | ($0.21B) | ($0.17B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.30B) | ($0.18B) | ($0.12B) | ($0.21B) | ($0.17B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-13.48 | $-10.21 | $-18.69 | $-69.33 | $-58.96 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.01B | 0.00B | 0.00B |
| EBITDA | ($0.30B) | ($0.20B) | ($0.13B) | ($0.21B) | ($0.17B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Praxis Precision Medicines, Inc. data
About Praxis Precision Medicines, Inc. (PRAX) Income Statement
Praxis Precision Medicines, Inc. (PRAX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PRAX reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.30B) — a net profit margin of —.
Frequently asked questions
PRAX · 4 questionsPraxis Precision Medicines, Inc. (PRAX) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
PRAX revenuePRAX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08